News
MyChesCo on MSN55m
Traws Pharma Receives FDA Feedback on Flu Drug DevelopmentNEWTOWN, PA — Traws Pharma, Inc. (NASDAQ: TRAW) announced receipt of key guidance from the U.S. Food and Drug Administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback